Insider Transactions in Q4 2025 at Akero Therapeutics, Inc. (AKRO)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 09
2025
|
Yuan Xu |
SELL
Sale (or disposition) back to the issuer
|
Direct |
9,398
-100.0%
|
-
|
|
Dec 09
2025
|
Tomas J. Heyman |
SELL
Sale (or disposition) back to the issuer
|
Direct |
9,398
-100.0%
|
-
|
|
Dec 09
2025
|
Seth Loring Harrison |
SELL
Sale (or disposition) back to the issuer
|
Direct |
145,699
-100.0%
|
-
|
|
Dec 09
2025
|
Seth Loring Harrison |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
148,063
-100.0%
|
-
|
|
Dec 09
2025
|
Andrew Cheng President and CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
436,837
-100.0%
|
-
|
|
Dec 09
2025
|
Timothy Rolph Chief Scientific Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
282,149
-100.0%
|
-
|
|
Dec 09
2025
|
Chou Judy |
SELL
Sale (or disposition) back to the issuer
|
Direct |
9,398
-100.0%
|
-
|
|
Dec 09
2025
|
G. Walmsley Graham |
SELL
Sale (or disposition) back to the issuer
|
Direct |
102,398
-100.0%
|
-
|
|
Dec 09
2025
|
G. Walmsley Graham |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
1,200,000
-100.0%
|
-
|
|
Dec 09
2025
|
William Richard White Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
57,752
-100.0%
|
-
|
|
Dec 09
2025
|
Scott A. Gangloff Chief Technology Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
26,351
-100.0%
|
-
|
|
Dec 09
2025
|
Mark T Iwicki |
SELL
Sale (or disposition) back to the issuer
|
Direct |
9,398
-100.0%
|
-
|
|
Dec 09
2025
|
Jane Henderson |
SELL
Sale (or disposition) back to the issuer
|
Direct |
9,398
-100.0%
|
-
|
|
Dec 09
2025
|
Patrick Lamy |
SELL
Sale (or disposition) back to the issuer
|
Direct |
29,891
-100.0%
|
-
|
|
Dec 09
2025
|
Catriona Yale Chief Development Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
74,800
-100.0%
|
-
|
|
Dec 09
2025
|
Jonathan Young Chief Operating Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
200,189
-100.0%
|
-
|
|
Dec 09
2025
|
Jonathan Young Chief Operating Officer |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
60,000
-100.0%
|
-
|
|
Nov 26
2025
|
Jonathan Young Chief Operating Officer |
SELL
Bona fide gift
|
Direct |
9,259
-4.42%
|
-
|
|
Nov 25
2025
|
Timothy Rolph Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
152,678
+8.85%
|
$1,984,814
$13.02 P/Share
|
|
Nov 24
2025
|
Jonathan Young Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,550
+2.0%
|
$288,650
$23.51 P/Share
|
|
Nov 20
2025
|
Andrew Cheng President and CEO |
SELL
Bona fide gift
|
Direct |
74,538
-14.58%
|
-
|
|
Nov 17
2025
|
Timothy Rolph Chief Scientific Officer |
SELL
Bona fide gift
|
Direct |
37,100
-22.27%
|
-
|
|
Nov 12
2025
|
Andrew Cheng President and CEO |
SELL
Bona fide gift
|
Direct |
14,739
-2.8%
|
-
|
|
Nov 04
2025
|
Catriona Yale Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,266
+5.38%
|
$198,384
$24.73 P/Share
|
|
Oct 10
2025
|
Andrew Cheng President and CEO |
SELL
Open market or private sale
|
Direct |
30,000
-5.39%
|
$1,590,000
$53.98 P/Share
|
|
Oct 10
2025
|
Andrew Cheng President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+5.12%
|
$570,000
$19.87 P/Share
|
|
Oct 08
2025
|
G. Walmsley Graham |
BUY
Exercise of conversion of derivative security
|
Direct |
90,832
+25.76%
|
$1,816,640
$20.53 P/Share
|
|
Oct 08
2025
|
Andrew Cheng President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
52,212
+9.03%
|
$0
$0.62 P/Share
|
|
Oct 07
2025
|
Timothy Rolph Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
12,500
-3.51%
|
$575,000
$46.41 P/Share
|
|
Oct 07
2025
|
Timothy Rolph Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+6.53%
|
$350,000
$28.35 P/Share
|
|
Oct 01
2025
|
Jonathan Young Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
12,500
-3.03%
|
$587,500
$47.81 P/Share
|
|
Oct 01
2025
|
Jonathan Young Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+5.63%
|
$262,500
$21.1 P/Share
|